Lexicon Pharmaceuticals Inc LXRX インサイダー取引

Lexicon Pharmaceuticals Inc (LXRX) インサイダー取引

フィルター:

日付	保有者名	取引株数	金額レンジ ($)	取引種別	価格レンジ ($)	届出終了時の株数	% 変化
2026-06-03	Dr. Judith Lea SwainIndependent Director	89.31k	0.00	Derivative Exercise and Retained Stock	-	174.49k	104.86%
2026-06-03	Ms. Diane E. SullivanIndependent Director	89.31k	0.00	Derivative Exercise and Retained Stock	-	126.12k	242.63%
2026-06-03	Mr. Christopher J. SobeckiIndependent Director	89.31k	0.00	Derivative Exercise and Retained Stock	-	293.18k	43.81%
2026-06-03	Mr. Ivan H. CheungIndependent Director	89.31k	0.00	Derivative Exercise and Retained Stock	-	89.31k	-
2026-06-03	Dr. Samuel L. BarkerIndependent Director	89.31k	0.00	Derivative Exercise and Retained Stock	-	213.77k	71.76%
2026-06-03	Mr. Philippe J. AmouyalIndependent Director	89.31k	0.00	Derivative Exercise and Retained Stock	-	374.49k	31.32%
2026-06-03	Mr. Raymond DebbaneIndependent Chairman of the Board	89.31k	0.00	Derivative Exercise and Retained Stock	-	2.00M	4.69%
2026-04-30	Artal Group S.A.法人	20.42M	0.00	Derivative Exercise and Retained Stock	-	175.16M	13.20%
2026-02-28	Ms. Wendy E. McDermottSVP of HR	156.30k	0.00	Derivative Exercise and Retained Stock	-	277.95k	128.49%
2026-02-28	Ms. Wendy E. McDermottSVP of HR	-68.11k	100.12k	Derivative Exercise and Sale	1.47	277.95k	-
2026-02-28	Ms. Rachel Yap MartensSenior VP of Partnerships & Corporate Strategy	31.26k	0.00	Derivative Exercise and Retained Stock	-	31.26k	-
2026-02-28	Ms. Rachel Yap MartensSenior VP of Partnerships & Corporate Strategy	-35.83k	52.66k	Derivative Exercise and Sale	1.47	31.26k	-
2026-02-28	Dr. Craig B. GranowitzSenior VP & Chief Medical Officer	203.18k	0.00	Derivative Exercise and Retained Stock	-	323.43k	168.96%
2026-02-28	Dr. Craig B. GranowitzSenior VP & Chief Medical Officer	-109.10k	160.37k	Derivative Exercise and Sale	1.47	323.43k	-
2026-02-28	Dr. Suma GopinathanSVP of Discovery	75.61k	0.00	Derivative Exercise and Retained Stock	-	150.13k	101.47%
2026-02-28	Dr. Suma GopinathanSVP of Discovery	-24.34k	35.78k	Derivative Exercise and Sale	1.47	150.13k	-
2026-02-28	Ms. Lisa M. DeFrancescoSVP of Investor Relations & Corporate Communications	78.29k	0.00	Derivative Exercise and Retained Stock	-	93.87k	502.61%
2026-02-28	Ms. Lisa M. DeFrancescoSVP of Investor Relations & Corporate Communications	-74.57k	109.62k	Derivative Exercise and Sale	1.47	93.87k	-
2026-02-28	Mr. Scott M. CoianteSenior VP & CFO	105.36k	0.00	Derivative Exercise and Retained Stock	-	105.36k	-
2026-02-28	Mr. Scott M. CoianteSenior VP & CFO	-54.88k	80.68k	Derivative Exercise and Sale	1.47	105.36k	-
2026-02-28	Mr. Brian T. CrumSenior VP, General Counsel & Secretary	167.99k	0.00	Derivative Exercise and Retained Stock	-	428.80k	64.41%
2026-02-28	Mr. Brian T. CrumSenior VP, General Counsel & Secretary	-105.02k	154.38k	Derivative Exercise and Sale	1.47	428.80k	-
2026-02-28	Dr. Michael S. ExtonCEO & Director	298.43k	0.00	Derivative Exercise and Retained Stock	-	298.43k	-
2026-02-28	Dr. Michael S. ExtonCEO & Director	-204.83k	301.10k	Derivative Exercise and Sale	1.47	298.43k	-
2026-02-25	Mr. Raymond DebbaneIndependent Chairman of the Board	2.00k	2.98k	買い	1.49	1.91M	0.11%
2026-02-23	Mr. Raymond DebbaneIndependent Chairman of the Board	100.00k	147.00k	買い	1.47	1.90M	5.54%
2026-02-19	Mr. Raymond DebbaneIndependent Chairman of the Board	150.00k	219.76k	買い	1.44 - 1.48	1.80M	9.07%
2026-02-13	Mr. Raymond DebbaneIndependent Chairman of the Board	268.50k	352.89k	買い	1.31 - 1.32	1.65M	19.38%
2026-02-02	Artal Group S.A.法人	1.54M	2.00M	買い	1.30	199.04M	0.78%